Multiplex PCR for rapid detection of minute virus of mice, bovine parvovirus, and bovine herpesvirus during the manufacture of cell culture-derived biopharmaceuticals

Biotechnology and Bioprocess Engineering

Volumn 15, Issue 6, 2010, Pages 1031-1037

  Bae, Jung Eun ^a   Kim, In Seop ^a  

^a Hannam University   (South Korea)

Author keywords

bovine herpesvirus; bovine parvovirus; CHO cell; minute virus of mice; multiplex PCR

Indexed keywords

BOVINE HERPESVIRUS; BOVINE PARVOVIRUS; CHO CELL; MINUTE VIRUS OF MICE; MULTIPLEX PCR;

ANIMAL CELL CULTURE; CELLS; COMPUTER VIRUSES; MAMMALS; MANUFACTURE; MULTIPLEXING; POLYMERASE CHAIN REACTION; VIRUSES;

CELL CULTURE;

ANIMAL CELL; ARTICLE; BOCAVIRUS; BOVINE HERPES VIRUS; CELL CULTURE; CHO CELL; CONTROLLED STUDY; DRUG MANUFACTURE; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARVOVIRUS; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION;

BOVINAE; BOVINE PARVOVIRUS; CRICETULUS GRISEUS; HERPESVIRIDAE; MAMMALIA; MINUTE VIRUS OF MICE;

EID: 79952664832     PISSN: 12268372     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12257-009-3137-6     Document Type: Article

References (28)

1. Merten, O. -W. (2002) Virus contaminations of cell cultures -A biotechnological view. Cytotechnol. 39: 91-116.
2. Committee for Proprietary Medicinal Products (CPMP), The European Agency for the Evaluation of Medicinal Products: Human Medicines Evaluation Unit (1996) Note for guidance on virus validation studies: the design, contribution and interpretation of studies validating the inactivation and removal of viruses (CPMP/BWP/268/95).
3. International Conference on Harmonisation (1998) Q5A Viral safety evaluation of biotechnology products derived from cell lines of human or animal origin. Fedral Register 63: 51074-51084.
4. World Health Organization (1998) WHO requirements for the use of animal cells as in vitro substrates for the production of biological. Dev. Bio. Stand. 93: 141-171.
5. Minor, P. D. (1996) Mammalian cells and their contaminants. Dev. Biol. Standard. 88: 25-29.
6. Adamson, S. R. (1998) Experiences of virus, retrovirus, and retrovirus-like particles in Chinese hamster ovary (CHO) and hybridoma cells used for production of protein therapeutics. Dev. Biol. Stand. 93: 89-96.
7. Garnick, R. L. (1996) Experience with viral contamination in cell culture. Dev. Biol. Stand. 88: 49-56.
8. Nicklas, W., V. Kraft, and B. Meyer (1993) Contamination of transplantable tumors, cell lines, and monoclonal antibodies with rodent viruses. Lab. Anim. Sci. 43: 296-300.
9. Robertson, J. S. (1996) Strategy for adventitious agent assays. Dev. Biol. Stand. 88: 37-40.
10. Eloit, M. (1999) Risks of virus transmission associated with animal sera or substitutes and methods of control. Dev. Biol. Stand. 99: 9-16.
11. Garnick, R. L. (1998) Raw materials as a source of contamination in large-scale cell culture. Dev. Biol. Stand. 93: 21-29.
12. Kniazeff, A. J. (1973) Endogenous virus contaminants in fetal bovine serum and their role in tissue culture contamination. pp. 233-242. In: J. Fogh (ed.). Contamination in Tissue Culture. Academic Press, NY, USA.
13. Immelmann, A., O. Stamm, and K. Tarrach (2005) Validation and quality procedures for virus and prion removal in biopharmaceuticals. BioProcess Int. 3: 38-44.
14. Wit, C., C. Fautz, and Y. Xu (2000) Real-time quantitative PCR for retrovirus-like particle quantification in CHO cell culture. Biologicals 28: 137-148.
15. Zhan, D., M. R. Roy, C. Valera, J. Cardenas, J. C. Vennari, J. W. Chen, and S. Liu (2002) Detection of minute virus of mice using real time quantitative PCR in assessment of virus clearance during the purification of mammalian cell substrate derived biotherapeutics. Biologicals 30: 259-270. (Pubitemid 36268961)
16. Caterina, K. M., S. Frasca Jr, T. Grirshick, and M. I. Khan (2004) Development of a multiplex PCR for detection of avian adenovirus, avian reovirs, infectious bursal disease virus, and chicken anemia virus. Mol. Cell. Probes 18: 293-298.
17. Kärber, J. (1931) Beitrag zur kollectiven Behandlung pharmakologische Reihenversuche. Arch. Exp. Path. Pharmak. 162: 480-483.
18. Crawford, L. V., E. Follett, and M. G. Burdon (1969) The DNA of a minute virus of mice. J. Gen. Virol. 4: 37-46.
19. Boschetti, N., K. Wyss, A. Mischler, T. Hostettler, and C. Kempf (2003) Stability of minute virus of mice against temperature and sodium hydroxide. Biologicals 31: 181-185. (Pubitemid 37006336)
20. Lubna, A., B. K. Murray, R. L. Renberg, K. L. O'Neill, H. Porter, J. B. Jensen, and F. B. Johnson (2006) Cell death in bovine parvovirus-infected embryonic bovine tracheal cells is mediated by necrosis rather than apoptosis. J. Gen. Virol. 87: 2539-2548.
21. Sandals, W. C. D., R. Charles, and A. H. Meek (1995) Prevalence of bovine parvovirus infection in Ontario dairy cattle. Can. J. Vet. Res. 59: 81-86.
22. Afshar, A. and M. D. Eaglesome (1990) Viruses associated with bovine semen. Vet. Bull. 60: 93-109.
23. Wyler, R., M. Engels, and M. Schwyzr (1989) Infectious bovine rhinotracheitis/vulvovaginitis (BHV-1). pp. 1-72. In: G. Wittmann (ed.). Herpesvirus disease of cattle, horse and pigs. Kluwer Academic Publishers, Boston, USA.
24. Kou, X., Q. Wu, D. Wang, and J. Zhang (2008) Simultaneous detection of norovirus and rotavirus in oyster by multiplex RT-PCR. Food Control 19: 722-726. (Pubitemid 351168661)
25. Falcone, E., M. Tollis, and G. Conti (2000) Bovine viral diarrhea disease associated with a contaminated vaccine. Vaccine 18: 387-388.
26. Kappler, A., C. Lutz-Wallace, T. Sapp, and M. Sidhu (1996) Detection of bovine polyomavirus contamination in fetal bovine sera and modified live viral vaccines using polymerase chain reaction. Biologicals 24: 131-135. (Pubitemid 26335417)
27. Wilbur, L. A., J. E. Evermann, R. L. Levings, I. R. Stoll, D. E. Starling, C. A. Spillers, G. A. Gustafson, and A. J. McKeirnan (1994) Abortion and death in pregnant bitches associated with a canine vaccine contaminated with bluetongue virus. J. Am. Vet. Med. Assoc. 204: 1762-1765.
28. Wessman, S. J. and R. L. Levings (1999) Benefits and risks due to animal serum used in cell culture production. Dev. Biol. Standard. 99: 3-8.